Synthesis of 7-carboxyalkylthio-5,6,7,8-tetrahydro-1H-pyrazolo[3,4-e]diazepin-4-ones
DOI:
https://doi.org/10.24959/ophcj.14.791Keywords:
1H-pyrazolo[3, 4-e][1, 4]diazepin-4-ones, thioalkancarboxylic acids, 5-amino-N-(2, 2-dialkyloxyethl) pyrazol-4-carboxamides, exo-funсtionalization, cyclocondensationAbstract
The article describes the method of synthesis of a new type of pyrazolo[3,4-e][1,4]diazepin-4-ones substituted in position 7 by fragments of thioalkane carboxylic acids. The literature reference considers the synthetic and biological studies of heterocyclic compounds with exo-functionalized fragments of thioalkan carboxylic acids and it substantiates the expediency of our investigation. The results of the research are development of an effective one pot method for the target compounds, which is based on the intramolecular cyclization of 5-amino-N-(2,2-dialkyloxyethyl)pyrazole-4-carboxamides in the solution of formic acid with thioalkan carboxylic acids. The synthesis of the starting 5-aminopyrazolo- 4-carboxamides has been performed by condensation of 2-cyano-N-(2,2-dimethoxy)-3-dimetylaminoacryl(croton) amides with alkyl hydrazines or hydrolytic cleavage of 5-(2,2-dietoxyethyl)-1,5-dihydropyrazolo-4Н-[3,4-d]pirimidin- 4-ones. The scheme of this reaction proposed involves the intramolecular cyclocondensation with the initial formation of the corresponding 7-hydroxy-5,6,7,8-tetrahydropyrazolo[3,4-e][1,4]diazepin-4(1H)-ones, and further replacement of the hydroxyl group for the carboxyalkylthiol residue in the acidic medium. The structure of the compounds obtained has been proven using the methods of IR-, NMR 1H 13C-spectroscopy, mass-spectra and elemental analysis. The substantial evidence of the diazepine cycle formation is the presence of multiplets of protons H6 in the range of 3.16- 3.50 ppm and multiplets of protons H7 in the range of 4.89-5.17 ppm in the 1Н NMR spectra.
Downloads
References
- Mamouni A., Daich A., Decroix B. Synthetic Communications, 1997, Vol. 27, No.13, pp.2241-2249.
- Cucl A., Daich A., Decroix B., Sanz G., Hijfte L.V. Heterocycles, 2004, Vol. 64, pp.33-39.
- Pigeon P., Decroix B. Synthetic Communications, 1997, Vol. 27, No.8, pp.1423-1431.
- Chihab-Eddine A., Diach A., Jilale A., Decroix B. Journal of Heterocyclic Chemistry, 2000, Vol. 37, No.6, pp.1543-1548.
- Surikova O.V., Zachinyaeva A.V., Mikhailovskii A.G., Zachinyaev Y.V. Chemistry of Heterocyclic Compounds, 2011, Vol. 46, No.12, pp.1471-1475.
- Luebbers T., Angehrn P., Herzig S., Gmuender H., Herzig S. Bioorganic and Medicinal Chemistry Letters, 2007, Vol. 17, pp.4708-4714.
- Fardis M., Jin H., Jabri S., Cai R.Z., Mish M., Tsiang M., Cim C.U. Bioorganic and Medicinal Chemistry Letters, 2006, Vol. 16, No.15, pp.4031-4035.
- Butler D.E., Leonard J.D., Coprathe B.W., L’Italien Y.J., Pavia M.R., Hershenson F.M., Posche P.H., Marriott J.G. Journal of Medicinal Chemistry, 1987, Vol. 30, No.3, pp.498-503.
- De Wald H.A., Lobbestael S., Butler D.E. Journal of Medicinal Chemistry, 1977, Vol. 20, No.12, pp.1562-1569.
- Fitgerald J.E., Iglesia F.A., Mcluire. Fundamental and Applied Toxicology, 1984, Vol. 4, No.2, pp.178-190.
- Baraldi P.G., Mantredini S., Poschel B.P.H. Journal of Medicinal Chemistry, 1985, Vol. 28, No.5, pp.683-686.
- De Wald H.A., Lobbestael S., Butler D.E., Journal of Medicinal Chemistry, 1981, Vol. 24, No.8, pp.982-987.
- Nagosoka T., Tamano H., Maekova T., Homaguchi F. Heterocycles, 1987, Vol. 26, No.3, pp.617-624.
- Boulouard M., Pallemague P., Alsaidi A., Roult S. Journal of Heterocyclic Chemistry, 2000, Vol. 37, pp.1743-1749.
- Bol’but A.V., Kemskii S.V., Vovk M.V. Zhurnal Organicheskoi Khimii – Russian Journal of Organic Chemistry, 2014, Vol. 40, No.4, pp.578-584.
- Bol’but A.V., Kemskii S.V., Vovk M.V. Zhurnal Organicheskoi Khimii – Russian Journal of Organic Chemistry, 2012, Vol. 48, No.7, pp.994-1004.
- Humber L.G., Davis M.A., Beau G., Charest M.P. Canadian Journal of Chemistry, 1968, Vol. 46, No.19, pp.2981-2988.
- Kessar S.V., Jit P., Mundra K.P., Lumb A.K. Journal of the Chemistry Soсiety (C). 1971, pp.266-269.
- Rozwadowska M.D., Sulime A. Tetrahedron, 2001, Vol. 57, No.16, pp.3499-3506.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2014 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors publishing their works in the Journal of Organic and Pharmaceutical Chemistry agree with the following terms:
1. Authors retain copyright and grant the journal the right of the first publication of the work under Creative Commons Attribution License allowing everyone to distribute and re-use the published material if proper citation of the original publication is given.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book) providing proper citation of the original publication.
3. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on authors’ personal websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).